Curcumin Oligosaccharides (Gluco-oligosaccharides) Penetrate the Blood-Brain Barrier in Mouse Brain: Glycoside (Polysaccharide) Modification Approach for Brain Drug Delivery Across the Blood-Brain Barrier and Tumor Drug Delivery

被引:5
|
作者
Hamada, Hiroki [1 ]
Nakayama, Takahiro [2 ]
Shimoda, Kei [3 ]
Matsuura, Nobuyasu [2 ]
Hamada, Hatsuyuki [4 ]
Iwaki, Takafumi [5 ]
Kiriake, Yuya [6 ]
Saikawa, Tomohiro [7 ]
机构
[1] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Japan
[2] Kyorin Univ, Sch Med, Dept Med Physiol, Tokyo, Japan
[3] Oita Univ, Fac Med, Dept Biomed Chem, Oita, Japan
[4] Natl Inst Fitness & Sports Kanoya, Sch Phys Educ, Kagoshima, Japan
[5] Oita Univ, Fac Med, Dept Biophys, Oita, Japan
[6] Yamaguchi Univ, Fac Med & Hlth Sci, Yamaguchi, Japan
[7] Junshin Gakuen Univ, Dept Nursing, Fukuoka, Japan
关键词
drug delivery technique; blood-brain barrier; curcumin glucooligosaccharide; glycosylation; brain drug delivery; tumor drug delivery;
D O I
10.1177/1934578X20953653
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to expand our drug delivery technique by glycosylation of chemical into brain delivery, it was demonstrated that oligosaccharide and monosaccharide modifications of curcumin enhanced its crossing ability of the blood-brain barrier (BBB) in mice. The brain sample prepared by glycosidase-catalyzed hydrolysis of brain tissue homogenates of mice, to which curcumin gluco-oligosaccharides were intraperitoneally injected, contained curcumin at 116 ng/1 g of tissue of brain, indicating that curcumin modified with gluco-oligosaccharides residues can smoothly cross the BBB in mouse brain. The brain samples of mice, which were treated with curcumin monosaccharide or curcumin itself, contained curcumin at 18 ng and 0 ng per 1 g of tissue of brain, respectively. On the other hand, after the administration of curcumin gluco-oligosaccharides to C57131, mouse with a large tumor for 5 days, the tumor disappeared.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Blood-brain barrier as dynamic interface for drug delivery to brain - Preface
    Tsuji, A
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 143 - 144
  • [32] Promoting Drug Delivery to the Brain by Modulating the Transcytosis Process across the Blood-Brain Barrier
    Zhang, Li
    Mao, Zhennan
    Li, Weibin
    Chi, Siyu
    Cheng, Hemei
    Wang, Zijun
    Wang, Caixia
    Liu, Zhihong
    ACS APPLIED MATERIALS & INTERFACES, 2025,
  • [33] Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
    Parodi, Alessandro
    Rudzinska, Magdalena
    Deviatkin, Andrei A.
    Soond, Surinder M.
    Baldin, Alexey, V
    Zamyatnin, Andrey A., Jr.
    PHARMACEUTICS, 2019, 11 (05):
  • [34] The blood-brain barrier: Physiology and strategies for drug delivery
    Pandit, Rucha
    Chen, Liyu
    Gotz, Jurgen
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 165-166 (165-166) : 1 - 14
  • [35] Circadian Rhythms of the Blood-Brain Barrier and Drug Delivery
    Kim, Mari
    Keep, Richard F.
    Zhang, Shirley L.
    CIRCULATION RESEARCH, 2024, 134 (06) : 727 - 747
  • [36] The blood-brain barrier: structure, regulation, and drug delivery
    Wu, Di
    Chen, Qi
    Chen, Xiaojie
    Han, Feng
    Chen, Zhong
    Wang, Yi
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [37] Peptide Shuttles for Blood-Brain Barrier Drug Delivery
    Sanchez-Navarro, Macarena
    Giralt, Ernest
    PHARMACEUTICS, 2022, 14 (09)
  • [38] Drug delivery and in vitro models of the blood-brain barrier
    Cucullo, L
    Aumayr, B
    Rapp, E
    Janigro, D
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (01) : 89 - 99
  • [39] Nanoscale drug delivery systems and the blood-brain barrier
    Alyautdin, Renad
    Khalin, Igor
    Nafeeza, Mohd Ismail
    Haron, Muhammad Huzaimi
    Kuznetsov, Dmitry
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 795 - 811
  • [40] Pain and the blood-brain barrier: obstacles to drug delivery
    Wolka, AM
    Huber, JD
    Davis, TP
    ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (08) : 987 - 1006